Hookworm infection remains one of the most common parasitic diseases on earth, affecting several hundred million people, mostly in tropical and subtropical regions with poor sanitation. Mebendazole, sold under brand names including Vermox, is one of the oldest and most widely used treatments for it. This article lays out what the clinical evidence actually shows about mebendazole's effectiveness against hookworm, the dosing regimens supported by that evidence, why the standard course is three days rather than a single pill, and what a patient should reasonably expect during and after treatment.

What Hookworm Does Inside the Body

Hookworm disease in humans is caused by two species, Necator americanus and Ancylostoma duodenale. Infection begins when larvae in contaminated soil penetrate bare skin, most often on the feet. The larvae travel through the bloodstream to the lungs, are coughed up and swallowed, and mature into adult worms in the small intestine, where they attach to the mucosal lining and feed on blood. A single worm draws only a small amount of blood daily, but heavy, chronic infections, common in children and pregnant women in endemic regions, produce a slow, cumulative iron-deficiency anemia and protein loss that can impair growth, cognitive development, and pregnancy outcomes. This is why treating hookworm is not a cosmetic matter of "getting rid of worms" but a genuine matter of protecting a person's blood, nutrition, and, in the case of a pregnant mother, the wellbeing of her unborn child as well.

How Mebendazole Works Against the Parasite

Mebendazole belongs to the benzimidazole class of anthelmintics. It works by binding selectively to a structural protein called beta-tubulin inside the worm's cells, blocking the assembly of microtubules the parasite needs to absorb glucose and maintain its own cellular structure. Deprived of glucose, the worm's glycogen stores run out, its energy production collapses, and it dies over the course of days rather than instantly. This selective binding is possible because the tubulin of nematode worms differs enough from human tubulin that the drug can exploit the parasite's biology while largely sparing the host's own cells, a distinction that is itself a small illustration of how precisely differentiated created life is at the molecular level, right down to the proteins two different organisms use for the same basic job. Practically, mebendazole is also poorly absorbed from the human gut, generally less than ten percent of an oral dose reaches the bloodstream. That is a therapeutic advantage here, not a flaw: the drug stays concentrated in the intestinal lumen, exactly where the hookworms live, which is part of why systemic side effects are uncommon at standard doses.

What the Clinical Evidence Actually Shows

Mebendazole has been used against soil-transmitted helminths, including hookworm, roundworm (Ascaris), and whipworm (Trichuris), since the 1970s, and it is approved by the FDA for these indications. The evidence base is large, but it also contains an important nuance that a careful reader should understand: mebendazole's efficacy against hookworm depends heavily on the dosing schedule used.

A widely cited systematic review and meta-analysis by Keiser and Utzinger, published in JAMA in 2008, pooled results from numerous randomized and comparative trials of anthelmintic drugs against soil-transmitted helminths. It found that a single 500 mg dose of mebendazole cured hookworm infection in only a modest proportion of patients, considerably lower than its cure rate against Ascaris or pinworm, and lower than single-dose albendazole's performance against hookworm specifically. This is precisely why single-dose mebendazole is not the recommended regimen for hookworm even though it is often adequate for other worms. The standard, better-supported regimen for hookworm is 100 mg taken twice daily for three consecutive days, a schedule that in clinical trials and long-standing clinical practice achieves cure rates in the range of roughly 90 to 95 percent, with substantial reductions in egg output even in the minority of cases that are not fully cleared. Cochrane reviews of deworming trials in soil-transmitted helminth infections similarly support multi-day benzimidazole courses as more reliable for hookworm than single-dose regimens, while noting that egg-reduction rates, a proxy for worm burden, respond well even when complete parasitological cure is not achieved. The World Health Organization's large-scale preventive chemotherapy programs, which treat hundreds of millions of school-age children annually, generally favor single-dose albendazole for hookworm precisely because of this efficacy gap, reserving multi-day mebendazole courses for individual clinical treatment or as an alternative where albendazole is unavailable.

Dosing: What the Three-Day Course Involves

For adults and children over two years of age, the standard treatment for hookworm is mebendazole 100 mg by mouth twice daily for three consecutive days. Unlike some anthelmintics, the dose is not adjusted by body weight, a reflection of the drug's local, gut-confined action rather than a systemic dose-response relationship. It can be taken with or without food, though taking it with a fatty meal modestly increases absorption, which is not typically a concern at these doses but is worth knowing. The chewable tablet formulation can be chewed, crushed, or swallowed whole.

Mebendazole is generally avoided in the first trimester of pregnancy because of teratogenicity signals seen in high-dose animal studies, though the World Health Organization has permitted its use in the second and third trimesters in endemic regions where untreated hookworm anemia poses its own well-documented risk to mother and child. This is exactly the kind of decision that belongs to a woman and her own physician, weighing the specific severity of her infection against the theoretical risk of the drug, rather than a blanket rule applied without individual judgment. Use in children under two is similarly a matter for clinical discretion, since data in that age group are more limited even though WHO programs have used it from twelve months of age in high-burden settings.

What to Expect During Recovery

Mebendazole does not produce an instant kill. Because it works by starving the worm of glucose over time, most patients will not notice a dramatic, immediate event; adult worms are gradually detached and passed, largely unnoticed, in the stool over the days following treatment. Symptom improvement, particularly the fatigue and pallor associated with anemia, tends to lag behind parasitological cure, since red blood cell counts and iron stores need weeks to months to rebuild even after the worms are gone. For that reason, physicians frequently pair antiparasitic treatment with iron supplementation and dietary advice when anemia is present, since killing the worm addresses the cause but not the accumulated deficit.

Side effects at standard hookworm doses are generally mild, given how little of the drug is absorbed systemically. Abdominal pain, cramping, and diarrhea are the most commonly reported effects, sometimes more noticeable in people with a heavy worm burden as the parasites are cleared. Serious reactions, including hypersensitivity or blood count changes, are rare at this dosing and are more associated with the much higher, prolonged doses used for entirely different conditions such as certain tissue-dwelling parasitic infections, which is not the regimen used for hookworm. Because hookworm larvae live in soil and re-infection occurs through skin contact with contaminated ground, wearing shoes, improving sanitation, and practicing good hand hygiene are the practical, personal responsibility side of treatment; the drug clears the current infection, but it does not confer immunity against catching hookworm again from the same environment.

Key takeaway: Mebendazole, given as 100 mg twice daily for three days, is a well-evidenced and FDA-approved treatment for hookworm with cure rates around 90 to 95 percent, but the single 500 mg dose sometimes used in mass deworming programs is measurably less reliable against hookworm specifically, so patients should confirm with their physician which regimen and follow-up plan fits their situation.